Glaucoma Solutions
Powerful.
Predictable.
Proven.

iStent inject® W is the market-leader from the pioneering experts in Micro-Invasive Glaucoma Surgery (MIGS). It represents the next generation of Glaukos trabecular micro-bypass technology, which has been proven safe and effective in hundreds of thousands of eyes worldwide.
iStent inject® W creates two bypass pathways through the trabecular meshwork, resulting in multi-directional flow through Schlemm’s canal, and is advancing the standard of care for glaucoma patients.

As the corporate founder of MIGS,
Glaukos revolutionized the traditional glaucoma treatment and management paradigm.
About MIGS
Micro Stents. Macro Efficacy.
Micro Stents. Macro Efficacy.
See the latest clinical data around patient outcomes.
iStent inject® W builds on trabecular micro-bypass technology of iStent inject®, which has demonstrated efficacy across a wide range of clinical studies.

Resources for Your Practice
Our Comprehensive Support.
Your Uncompromising Patient Care.Integrating iStent inject® W into your practice helps you expand care, and provide a wider range of benefits to many of your patients. As a trusted industry leader—and the corporate founder of MIGS—we have the experience, tools, and training to make integration easy.

Clinical
Data
iStent®️ technologies have demonstrated efficacy across clinical studies
View Clinical Data
Market Access Support
Looking for
Reimbursement
Information?
Insurance
As a service to our customers, Glaukos provides a reimbursement & billing guide with sample claim forms. Here you’ll find information including coding options, coverage highlights, as well as information for private payers.

Explore Patient Resources for Glaucoma Treatment Options
View Patient WebsiteFind a Physician Offering iStent® or iStent inject® W
Go to Physician LocatorContact Us Today to Integrate iStent inject® W Into Your Practice
Complete the form to get started with offering iStent inject® W to your patients.
Request More Info
"*" indicates required fields